Skip to main content
. 2016 Oct 31;2:16076. doi: 10.1038/cddiscovery.2016.76

Figure 3.

Figure 3

Role of caspase-2 in apoptosis induced by etoposide or gemcitabine. Mouse cells expressing E1A 12S (a) or human cells expressing genomic E1A (b) were treated with etoposide or gemcitabine in the absence (black bars) or presence (gray bars) of the caspase-2-specific inhibitor, zVDVAD (200 μM) for 18 h, and specific Cr51 release was determined (mean±S.E.M.; n=3, ***P<0.001). (c) E1A 12S-positive mouse cells (E1A) or caspase-2 siRNA-expressing E1A 12S-positive mouse cells (E1AiC2) were treated with the chemical NO generator, DETANoNoate (NO) (250 μM), TNFα (20 ng/ml), etoposide (400 μM) or gemcitabine (50 μM) for 18 h, and specific Cr51 release was determined (mean±S.E.M.; n=3, ***P<0.001).